SC
ATYR

Steven Cohen’s aTyr Pharma ATYR Stock Holding History

Steven Cohen’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2K Buy
+37,278
New +$24.4K ﹤0.01% 3867
2025
Q3 		– Sell
-988,677
Closed -$5.01M – 2759
2025
Q2 		$5.01M Sell
988,677
-1,855,422
-65% -$7.3M 0.01% 967
2025
Q1 		$8.59M Sell
2,844,099
-2,039,098
-42% -$7.43M 0.02% 738
2024
Q4 		$17.7M Buy
+4,883,197
New +$14.8M 0.04% 494

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steven Cohen's ATYR Position: Q2 2026 in Review

Steven Cohen opened a new position in aTyr Pharma (ATYR) in Q2 2026: 37,278 shares worth $22.2K. The stake represents ﹤0.01% of the portfolio and ranks #3867 among its holdings. This is a return to the name: Steven Cohen previously reported a position in ATYR as recently as Q2 2025.

Steven Cohen first reported a position in ATYR in Q4 2024 and has held it in 4 quarters since. The position peaked at $17.7M in Q4 2024. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Steven Cohen held 37,278 shares of aTyr Pharma worth $22.2K as of Q2 2026.
  • aTyr Pharma was a new Steven Cohen position in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3867 holding.
  • Steven Cohen first reported a position in aTyr Pharma in Q4 2024 and has held it in 4 quarters since.
  • Steven Cohen's aTyr Pharma position peaked at $17.7M in Q4 2024.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.